Contents

Current Drug Targets - Cardiovascular & Hematological Disorders, Volume 5 - Number 3

Editorial [Hot Topic:Fighting Antibody Mediated Rejection (Guest Editor: Robert Zhong )]

, 5(3): 197 - 198

Robert Zhong


DOI: 10.2174/1568006054064780




Pathological Features of Antibody-Mediated Rejection

, 5(3): 199 - 214

Akira Shimizu and Robert B. Colvin


DOI: 10.2174/1568006054064744




Modulating Alloimmune Responses with Plasmapheresis and IVIG

, 5(3): 215 - 222

Daniel S. Warren, Christopher E. Simpkins, Matthew Cooper and Robert A. Montgomery


DOI: 10.2174/1568006054064735




Targeting Antibody-Mediated Rejection in the Setting of ABOIncompatible Infant Heart Transplantation: Graft Accommodation vs. B Cell Tolerance

, 5(3): 223 - 232

Lori J. West


DOI: 10.2174/1568006054064762




Antibody Mediated Rejection in Pig-To-Nonhuman Primate Xenotransplantation Models

, 5(3): 233 - 253

Emanuele Cozzi, Michela Severo, Erika Bosio, Federica Besenzon and Ermanno Ancona


DOI: 10.2174/1568006054064799




Beyond Antibody-Mediated Rejection: Hyperacute Lung Rejection as a Paradigm for Dysregulated Inflammation

, 5(3): 255 - 269

Bao H. Nguyen, Egon Zwets, Carsten Schroeder, Richard N. Pierson III and Agnes M. Azimzadeh


DOI: 10.2174/1568006054064753




B Cell Tolerance: Lessons from Transplantation

, 5(3): 271 - 275

Marilia Cascalho


DOI: 10.2174/1568006054064771




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science